slide_small1

 

Bioxiness Solution

Print

Bioxiness solution

Bioxiness is developing a novel class of antimicrobial drugs.  These drugs are small molecules engineered for enhanced bacteria uptake.  These compounds are being developed to inhibit previously underexplored crucial bacterial enzyme-targets.  Bioxiness’ compounds have the potential to be used as systemic antimicrobial drugs in multiple clinical areas.


The breadth and scope of Bioxiness’ scientific applications enable it to target a broad range of bacterial infections.  Unlike many other antibiotics, Bioxiness molecules are a novel class of compounds that are targeted towards crucial steps within the bacterial life cycle.  Because these are target-specific new molecules without prior use, the possibility for bacteria to survive and develop resistance is minimal.